[Significance of the treatment of trichomoniasis in gynecology and obstetrics].
D000022:Abortion, Spontaneous / Q000209:etiology; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D000994:Antitrichomonal Agents / Q000627:therapeutic use; D001064:Appendicitis / Q000150:complications; D005260:Female; D006801:Humans; D008795:Metronidazole / Q000627:therapeutic use*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D011645:Puerperal Infection / Q000209:etiology; D014247:Trichomonas Vaginitis / Q000188:drug therapy*; D002577:Uterine Cervical Diseases / Q000150:complications
D000981:Antiprotozoal Agents; D000994:Antitrichomonal Agents; D008795:Metronidazole
Znaczenie leczenia rzesistkowicy w ginekologii i połoznictwie.